Serine protease inhibitors
US6784182B2 · kind B2 · utility
12Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2002 |
| Grant date | Aug 31, 2004 |
| Priority date | — |
| Expiry date | Jul 6, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I) in which R2, X, Y, Cy, L and Lp(D)n have the meanings given in the specification, are inhibitors of the serine protease, factor Xa and are useful in the treatment of cardiovascular disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.